Skip to main content Skip to main navigation Skip to search Skip to footer

Endo Pharmaceuticals Implements Open Innovation Network With HCL and Other R&D Partners

Endo Pharmaceuticals Implements Open Innovation Network With HCL and Other R&D Partners

In an effort to diversify its product portfolio, Endo Pharmaceuticals quickly realized that it no longer could rely solely on a static R&D infrastructure to achieve its goals. It needed a cost-effective, scalable and agile innovation network built on value-based partnerships.

DOWNLOAD THE SUCCESS STORY

Kontaktieren Sie uns
MAX CHARACTERS: 10,000

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.

We will treat any information you submit with us as confidential. Please read our privacy statement for additional information.